Inhibition of Bone Resorption by Pamidronate Cannot Restore Normal Gain in Cortical Bone Mass and Strength in Tail-Suspended Rapidly Growing Rats
Open Access
- 1 July 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 12 (7) , 1058-1067
- https://doi.org/10.1359/jbmr.1997.12.7.1058
Abstract
To clarify how the changes in bone formation and resorption affect bone volume and strength after mechanical unloading, the effect of inhibition of bone resorption by a potent bisphosphonate, pamidronate, on bone mineral density (BMD), histology, and strength of hind limb bones was examined using tail‐suspended growing rats. Tail suspension for 14 days reduced the gain in the BMD of the femur at both the metaphysis rich in trabecular bone and the diaphysis rich in cortical bone. Treatment with pamidronate increased the total BMD as well as that of the metaphysis of the femur but had almost no effect on the BMD of the diaphysis in both control and tail‐suspended rats. Histological examinations revealed that 14‐day tail suspension caused a loss of secondary cancellous bone with a reduction in the trabecular number and thickness in comparison with control rats. In the femoral diaphysis, the diameter and cortical bone thickness increased to a lesser degree in tail‐suspended rats when compared with rats without tail suspension, and a marked reduction in bone formation and the layers of alkaline phosphatase–positive cells was observed at the periosteal side. Pamidronate treatment increased secondary cancellous bone but could not restore normal growth‐induced periosteal bone apposition and bone strength. Because the material strength of the femoral diaphysis at the tissue level was not affected by pamidronate treatment, the inability of pamidronate to prevent the reduction in physical strength of the femoral diaphysis does not appear to be due to a change in the quality of newly formed bone. These results demonstrate that tail suspension reduces the growth‐induced periosteal modelling drift and that the antiresorptive agent pamidronate is unable to restore normal periosteal bone apposition.Keywords
This publication has 25 references indexed in Scilit:
- Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonatesJournal of Bone and Mineral Research, 1996
- Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.Journal of Clinical Investigation, 1995
- Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized ratsJournal of Bone and Mineral Research, 1995
- Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilageJournal of Bone and Mineral Research, 1994
- Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomyJournal of Bone and Mineral Research, 1994
- Bone marrow from mechanically unloaded rat bones expresses reduced osteogenic capacity in vitroJournal of Bone and Mineral Research, 1994
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Journal of Clinical Investigation, 1993
- Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in ratsJournal of Bone and Mineral Research, 1990
- Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formationBone, 1989
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987